Quipt Home Medical (NASDAQ:QIPT – Get Free Report) and LENSAR (NASDAQ:LNSR – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.
Analyst Recommendations
This is a summary of current ratings and target prices for Quipt Home Medical and LENSAR, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Quipt Home Medical | 1 | 0 | 3 | 2 | 3.00 |
| LENSAR | 0 | 0 | 1 | 0 | 3.00 |
Quipt Home Medical currently has a consensus target price of $6.25, suggesting a potential upside of 151.00%. LENSAR has a consensus target price of $8.00, suggesting a potential upside of 3.90%. Given Quipt Home Medical’s higher probable upside, research analysts plainly believe Quipt Home Medical is more favorable than LENSAR.
Volatility and Risk
Profitability
This table compares Quipt Home Medical and LENSAR’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Quipt Home Medical | -1.95% | -4.51% | -2.01% |
| LENSAR | -34.03% | -49.02% | -21.12% |
Insider and Institutional Ownership
42.8% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 4.2% of Quipt Home Medical shares are owned by company insiders. Comparatively, 38.5% of LENSAR shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares Quipt Home Medical and LENSAR”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Quipt Home Medical | $245.92 million | 0.44 | -$2.78 million | ($0.15) | -16.60 |
| LENSAR | $48.87 million | 1.83 | -$14.38 million | ($1.46) | -5.27 |
Quipt Home Medical has higher revenue and earnings than LENSAR. Quipt Home Medical is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two stocks.
Summary
Quipt Home Medical beats LENSAR on 10 of the 14 factors compared between the two stocks.
About Quipt Home Medical
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
About LENSAR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.
